Our COO, Tanaka, and our business manager, Akane, Launched the IoMD working group at the Japan Digital Therapeutics Association.

Our CSO, Hiroaki Kato, was interviewed by Medical DX.

The article authored by Our COO, Daichi Tanaka, was published in Technical Information Institute.

Aillis will provide AI medical device development support.

Aillis appeared in Nikkei MJ.

Our CEO, Sho Okiyama, participated in a panel discussion at Galen Growth's webinar as a panelist.

Our CEO, Sho Okiyama, was interviewed by Nikkei Style.

Our CSO, Hiroaki Kato, gave a presentation at TSUNAGARU CHIKARA FES.

Our CSO, Hiroaki Kato, was interviewed by Japanese Cabinet Office National Strategic Special Zones.

Our CSO, Hiroaki Kato, has been re-elected as a councilor of the Japanese Ophthalmological AI Society.

Our CSO, Hiroaki Kato, has been reappointed as Clinical Associate Professor of Tokyo Medical and Dental University.

Our CSO, Hiroaki Kato, has been reappointed as Visiting Associate Professor at Chiba University Hospital.

Our CSO, Hiroaki Kato, has been reappointed as a part-time lecturer at Yokohama City University.

Our CSO, Hiroaki Kato, has been reappointed as a part-time lecturer at Graduate School at Tohoku University.

Yoshihiro Todoroki and Miho Nakamura were interviewed by Magazine for Medical Management Specialist.

Our CEO, Sho Okiyama, was interviewed by RECRUIT DOCTOR'S CAREER.

Our Executive Officer, Yasufumi Sakiji, was interviewed by ASCII STARTUP.

Our CSO, Hiroaki Kato, gave a lecture at Aomori Life Innovation Forum 2020.

Our CSO, Hiroaki Kato, gave a lecture at Japan Medical Association.

Our CEO, Sho Okiyama, gave a lecture at JMHA.